• Home
  • About
  • Education
    • Certification
    • Application for Certification
  • News and Events
    • 2019 AUA Game of Stones Presentations
  • Resources
  • Contact

The Question:

If a type 2 diabetic patient is on Metformin and receives iodinated contrast during SWL, Metformin should be withheld for at least 72 hours.

The Answer: False

According to the CDC, over 108 million Americans have diabetes or pre-diabetes.  Not surprisingly, many type 2 diabetics are also stone sufferers and will need the surgical management of their calculi.  Many of these patients will be on Metformin as a first line therapy.

While Metformin is safe and has very few side effects, it has been rarely associated with severe lactic acidosis, which can be fatal.  Because iodinated contrast can cause acute renal injury, the American College of Radiology in the past has recommended stopping Metformin before and after an IV contrast study because Metformin is eliminated through the kidneys and its accumulation could increase the risk of lactic acidosis.

The most recent ACR recommendations, however, have recognized that every case of Metformin lactic acidosis has occurred on patients that were inappropriately on Metformin.  As a consequence, current recommendations are that only patients with a eGFR < 30 ml/min/1.73m2 or evidence of acute kidney injury should have Metformin withheld for 48 hours after an iodinated contrast study or until kidney function “normalizes.”

Share

Category Search

  • AUA News
  • Events
  • News
  • PubMed Abstracts
  • Resources
  • Uncategorized
  • Urology Times Articles

 
 
 
 

About CUI

The Council for Urological Interests (CUI) is a 501c(6) non-profit organization created to provide a voice for lithotripsy providers and their partners in the urological community.

At its heart, CUI is dedicated to keeping shock wave lithotripsy appropriately available to the urologists needing it for their kidney stone patients.

Contact Us

Council for Urological Interests
PO Box 9856
Chapel Hill, NC 27514
Email: info@urologicalinterests.org

© 2022 Council for Urological Interests. All Rights Reserved.